The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 556-559

  Lanotte, Philippe ^b   Dubois, Frederic ^b   Pogam, Sophie Le ^b   Guerois, Claude ^b   Fimbel, Beatrice ^b   Bacq, Yannick ^b   Gruel, Yves ^b   Goudeau, Alain ^b   Barin, Francis ^a  

^a CHU BRETONNEAU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY;

EID: 0031821825     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517473     Document Type: Article

References (15)

1. Alter HJ. To C or not to C: these are the questions. Blood 1995; 85: 1681-95.
2. Tong MJ, El-Farra N, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-6.
3. Wilber JC, Polito A. Serological and virological diagnostic tests for hepatitis C virus infection. Semin Gastrointest Dis 1995; 6:13-9.
4. Couroucé AM, Barin F, Botte C, et al. A comparative evaluation of the sensitivity of seven anti-hepatitis C virus screening tests. Vox Sang 1995; 69:213-6.
5. Garson JA, Tuke PW, Makris M, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990; 336:1022-5.
6. Allain JP, Dailey SH, Laurian Y et al. Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs. J Clin Invest 1991; 88:1672-9.
7. Giuberti T, Ferrari C, Marchelli S, et al. Long-term follow-up of antihepatitis C virus antibodies in patients with acute non-A non-B hepatitis and different outcomes of liver disease. Liver 1992; 12:94-9.
8. Simon N, Couroucé AM, Lemarrec N, Trépo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46:504-11.
9. Lefrère JJ, Guiramand S, Lefrère F, et al. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 1997; 175:316-22.
10. Chamot E, Hirchel B, Wintsch J, François-Robert C. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 1990; 4:1275-7.
11. Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion." Blood 1993; 82:1010-5.
12. Marcellin P, Martinot-Peignoux M, Elias A, et al. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay. J infect Dis 1994; 170:433-5.
13. Poignet JL, Degos F, Bouchardeau F, Chauveau P, Couroucé AM. Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse. J Hepatol 1995; 23:740-1.
14. Naito M, Hayashi N, Hagiwara H. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19:871-7.
15. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66:122-9.